6505NCM205934: AMIFAMPRIDINE TABLE.
The AMIFAMPRIDINE TABLE is a the manufacturer industrial component. Key specifications include part_name_assigned_by_controlling_agency: AMIFAMPRIDINE TABLETS, 10MG, 100S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-686-6357, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | AMIFAMPRIDINE TABLETS, 10MG, 100S |
| NSN | 6505-01-686-6357 |
| SPECIAL FEATURES | POTASSIUM CHANNEL BLOCKER INDICATED FOR THE TREATMENT OF LAMBERT-EATON MATON MYASTHENIC SYNDROME (LEM) IN PATIENTS 6 TO LESS THAN 17 YEARS OF AGE; TABLETS ARE OVAL, WHITE TO OFF WHITE, AND DEBOSSED "10/110" ON ONE SIDE AND "JACOBUS" ON THE OTHER SIZE; BOTTLE OF 100 TABLETS; PRIOR TO DISPENSING STORE TABLETS IN A REFRIGERATOR BETWEEN 2C TO 8C (36F TO 46F), KEEP CONTAINER TIGHTLY CLOSED WITH DESICCANT CANISTER INSIDE AFTER OPENING; PROTECT FROM MOISTURE AND LIGHT; AFTER DISPENSING STORE TABLETS AT 20C TO 25C (68F TO 77F) FOR UP TO 3 MONTHS; EXCURSIONS PERMITTED BETWEEN 15C TO 30C (59F TO 86F) SEE USP CONTROLLED ROOM TEMPERATURES; POTENTIAL TREATMENT FOR BOTULINUM BOTULISM (BOT) NEUROTOXIN (TOXIN); RUZURGI CAN BE TAKEN WITHOUT REGARD TO FOOD. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | AMIFAMPRIDINE TABLETS, 10MG, 100S |